Epoprostenol Injection 1.5 mg/via; Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 1.5 mg/via;
Reference Brands: Flolan®(Us & Eu)
Category: Orphan Drugs
Epoprostenol infusion solution is a prostacyclin analogue that dilates pulmonary blood vessels, reducing blood pressure in PAH. It inhibits platelet aggregation, preventing blood clots. Benefits include improved exercise capacity, symptom relief, and enhanced quality of life in PAH patients, especially those with advanced disease.
Product Description: Epoprostenol infusion solution, marketed as Flolan® in the US and EU, is approved for pulmonary arterial hypertension. Regulatory dossiers include extensive clinical data, manufacturing details, and safety profiles submitted to FDA and EMA, supporting its approval for continued use. The solution is administered via continuous IV infusion, with dosing tailored individually. These dossiers ensure high-quality standards and efficacy. For in-depth insights into regulatory submissions, dossier requirements, and market approvals, visit PharmaTradz, your trusted source for pharmaceutical regulatory updates and industry insights.
Epoprostenol Injection — third party manufacturing & bulk supply
Epoprostenol Injection 1.5 mg/via; is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Epoprostenol Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Epoprostenol Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Pasireotide Diaspartate
Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg
Form: Injection
Reference Brands: Signifor (USA/EU)
View Details
Sepiapterin
Strength:
1000 mg, 250 mg
Form: Tablets / oral powder
Reference Brands: Sephience (USA/EU)
View Details
Glycerol Phenylbutyrate
Strength:
1.1 g/mL
Form: Oral Solution
Reference Brands: Ravicti (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
